Clinical trial
Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After…
NCT00385320 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00385320 |
|---|---|
| Title | Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months |
| Official title | To Assess the Efficacy, Immuno & Safety of 2 Doses of GSK HRV Vaccine at Different Virus Concentrations in Healthy Infants Aged 2 Months & Previously Uninfected With HRV, Concurrently Given With DTPw-HBV, Hib. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infections, Rotavirus |
| Intervention type | Biological |
| Interventions | HRV vaccine |
| Enrollment | 2,640 |
| Start date | May 31, 2001 |
| Primary completion | Apr 30, 2003 |
| Completion | Apr 30, 2003 |
| First posted | Oct 9, 2006 |
| Last update posted | Dec 27, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: